Radioisotopic imaging

Lerondel S, Le Pape A, Sene C, et al. (2001). Radioisotopic imaging allows optimization of adenovirus lung deposition for cystic fibrosis gene therapy. Human Gene Ther. 12 1-11. 

Figure 13.4 Ambis 4000 Radioisotopic Imager. (Photograph courtesy of...

Various computed tomography CT- scanners for industrial applications have been designed and constructed) They use as radiation sources X-ray tubes or gamma emitting radioisotopes and as detectors NaI(Tl)-scintillators for gamma rays and image intensifiers for X-rays. 

Safety. The principal concerns regarding nuclear medical imaging are those associated with the radiopharmaceuticals. Much research has gone into the selection of radiopharmaceuticals exhibiting minimal toxicities, rapid elimination from the body, and short half-life. The radioisotope must be... 

Radiochemical tracers, compounds labeled with radioisotopes (qv), have become one of the most powerful tools for detection and analysis in research, and to a limited extent in clinical diagnosis (see Medical IMAGING TECHNOLOGY). A molecule or chemical is labeled using a radioisotope either by substituting a radioactive atom for a corresponding stable atom in the compound, such as substituting for H, for or for P, and for for... 

Positron emission tomography (PET) is an imaging technique that relies on the emission of positrons from radionucleotides tagged to an injectable compound of interest. Each positron emitted by the radioisotope collides with an electron to emit two photons at 180° from each other. The photons are detected and the data processed so that the source of the photons can be identified and an image generated showing the anatomical localization of the compound of interest. 

Most disease-specific molecular and cellular processes involve low concentrations and have low capacities. Therefore, molecular imaging requires highly sensitive imaging modalities to detect and quantify the imaging probes as it is done with short-lived radioisotopes. Optical imaging and ultrasound are next in sensitivity. MRI would require too high contrast agent concentrations... 

Technetium-99m (the m signifies a metastable, or moderately stable, species) is generated in nuclear reactors and shipped to hospitals for use in medical imaging. The radioisotope has a half-life of 6.01 h. If a 165-mg sample of technetium-99m is shipped from a nuclear reactor to a hospital 125 kilometers away in a truck that averages 50.0 kmh. what mass of technetium-99m will remain when it arrives at the hospital ... 

The utilization of radioisotopes in the field of nuclear medicine has been promoted for various purposes. Among them, diagnostic applications have had much success during the past two decades. Technetium-99m, thallium-210 and iodine-123, for example, have been used as radioisotopes for imaging studies. 

DTPA has also been used in the peptide-based " in-DTPA-octreotide. Octreotide is a shortened peptide analog of somatostatin designed to be more stable in vivo. Radiolabeling of octreotide for diagnostic imaging applications with radioisotopes for PET or SPECT has been investigated,... 

---